CDC cuts Pfizer booster interval to five months
The Centers for Disease Control and Prevention (CDC) has recommended that people get a booster shot with the Pfizer-BioNTech vaccine five months after their first two shots, shortening the interval from the previous six-month regimen.
The new recommendation comes one day after the US Food and Drug Administration (FDA) changed its emergency authorisation for the shot to reflect a shorter dosing interval for the booster.
“Following the FDA’s authorisations, today’s recommendations ensure people are able to get a boost of protection in the face of omicron and increasing cases across the country,” CDC director Rochelle Walensky said.
The move also comes one day before a meeting of the CDC’s advisory committee on immunisation practices, which is expected to discuss recommending boosters for 12-to-15-year-olds with the Pfizer shot.
The dosing interval for the Moderna booster remains unchanged at six months after the first two shots.
Bloomberg. More stories like this are available on bloomberg.com
Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.
Please read our Comment Policy before commenting.